About Johns Hopkins Center for Viral Hepatits
Clinical Trials at Johns Hopkins Center for Viral Hepatits
During the past decade, Johns Hopkins Center for Viral Hepatits conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Center for Viral Hepatits"
#1 collaborator was "Novartis" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Johns Hopkins Center for Viral Hepatits
According to Clinical.Site data, the most researched conditions in "Johns Hopkins Center for Viral Hepatits" are
"Chronic Hepatitis C" (2 trials). Many other conditions were trialed in "Johns Hopkins Center for Viral Hepatits" in a lesser frequency.
Clinical Trials Intervention Types at Johns Hopkins Center for Viral Hepatits
Most popular intervention types in "Johns Hopkins Center for Viral Hepatits" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ribavirin" (2 trials), "albumin interferon alfa-2b" (2 trials) and "peginterferon alfa-2a" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Johns Hopkins Center for Viral Hepatits
The vast majority of trials in "Johns Hopkins Center for Viral Hepatits" are
2 trials for "All" genders.
Clinical Trials Status at Johns Hopkins Center for Viral Hepatits
Currently, there are NaN active trials in "Johns Hopkins Center for Viral Hepatits".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Johns Hopkins Center for Viral Hepatits,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Johns Hopkins Center for Viral Hepatits, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".